HLA-DRB1 and neuromyelitis optica: In this study we intended to establish a T cell-mediated animal model of NMO in the context of HLA-DRB1*03:01, utilizing hAQP4281-300 as the dominant hAQP4 determinant in that MHC II haplotype.